$ATRA
Atara Biotherapeutics, Inc.

2015 Q1 Form 10-K Financial Statement

#000156459015001038 Filed on February 26, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2014 2013 Q4
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.540M $12.71M
YoY Change -13.66% 238.03%
% of Gross Profit
Research & Development $5.767M $15.45M
YoY Change 93.46% 258.71%
% of Gross Profit
Depreciation & Amortization $6.000K $6.000K $0.00
YoY Change 500.0% 50.0%
% of Gross Profit
Operating Expenses $9.311M $28.16M
YoY Change 31.57% 226.83%
Operating Profit -$9.311M -$28.16M
YoY Change 31.57% 226.83%
Interest Expense $150.0K $130.0K
YoY Change 1400.0% 1200.0%
% of Operating Profit
Other Income/Expense, Net $153.0K $125.0K
YoY Change 941.67%
Pretax Income -$9.158M -$28.03M
YoY Change 29.51% 225.83%
Income Tax $2.000K -$25.00K
% Of Pretax Income
Net Earnings -$9.160M -$28.01M
YoY Change 29.95% 219.23%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$417.9K -$5.613M
COMMON SHARES
Basic Shares Outstanding 24.36M
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q1 2014 2013 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $166.7M $104.1M
YoY Change 168.87% 101.74%
Cash & Equivalents $71.33M $21.90M $51.62M
Short-Term Investments $95.40M $82.20M
Other Short-Term Assets $3.000M $1.900M
YoY Change 900.0% 850.0%
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $169.7M $106.0M $51.81M
YoY Change 172.39% 104.63%
LONG-TERM ASSETS
Property, Plant & Equipment $0.00 $0.00 $8.000K
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $100.0K $0.00 $12.00K
YoY Change -83.33%
Total Long-Term Assets $100.0K $100.0K $20.00K
YoY Change -83.33%
TOTAL ASSETS
Total Short-Term Assets $169.7M $106.0M $51.81M
Total Long-Term Assets $100.0K $100.0K $20.00K
Total Assets $169.8M $106.1M $51.83M
YoY Change 169.95% 104.83%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $800.0K $400.0K $606.0K
YoY Change -42.86% -33.33%
Accrued Expenses $500.0K $1.200M
YoY Change 150.0% 300.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $3.500M $2.700M $1.524M
YoY Change 25.0% 80.0%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $200.0K $200.0K $230.0K
YoY Change 0.0% 0.0%
Total Long-Term Liabilities $200.0K $200.0K $230.0K
YoY Change 0.0% 0.0%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.500M $2.700M $1.524M
Total Long-Term Liabilities $200.0K $200.0K $230.0K
Total Liabilities $3.700M $2.900M $1.754M
YoY Change 23.33% 61.11%
SHAREHOLDERS EQUITY
Retained Earnings -$50.05M -$12.88M
YoY Change
Common Stock $216.2M $2.201M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $166.1M $103.2M -$11.02M
YoY Change
Total Liabilities & Shareholders Equity $169.8M $106.1M $51.83M
YoY Change 169.98% 104.83%

Cashflow Statement

Concept 2015 Q1 2014 2013 Q4
OPERATING ACTIVITIES
Net Income -$9.160M -$28.01M
YoY Change 29.95% 219.23%
Depreciation, Depletion And Amortization $6.000K $6.000K $0.00
YoY Change 500.0% 50.0%
Cash From Operating Activities -$6.620M -$16.63M -$4.180M
YoY Change 126.71% 178.56%
INVESTING ACTIVITIES
Capital Expenditures $5.000K $46.00K $0.00
YoY Change 400.0% 1433.33%
Acquisitions
YoY Change
Other Investing Activities -$13.43M -$83.32M $0.00
YoY Change -40.07%
Cash From Investing Activities -$13.43M -$83.36M $0.00
YoY Change -40.1%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $69.49M $56.46M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 69.49M 70.27M 38.42M
YoY Change 415.89% 31.64%
NET CHANGE
Cash From Operating Activities -6.620M -16.63M -4.180M
Cash From Investing Activities -13.43M -83.36M 0.000
Cash From Financing Activities 69.49M 70.27M 38.42M
Net Change In Cash 49.44M -29.72M 34.24M
YoY Change -516.51% -162.69%
FREE CASH FLOW
Cash From Operating Activities -$6.620M -$16.63M -$4.180M
Capital Expenditures $5.000K $46.00K $0.00
Free Cash Flow -$6.625M -$16.68M -$4.180M
YoY Change 126.81% 179.19%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2014 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-28031000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
106026000
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
606000
CY2014 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
14380000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1910000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
12000
CY2013Q4 us-gaap Assets
Assets
51828000
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-12883000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-11017000
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
51828000
CY2014Q2 dei Entity Public Float
EntityPublicFloat
0
CY2013Q4 us-gaap Assets Current
AssetsCurrent
51808000
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8000
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
193000
us-gaap Net Income Loss
NetIncomeLoss
-4110000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
21897000
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
51615000
CY2014Q4 us-gaap Available For Sale Securities Current
AvailableForSaleSecuritiesCurrent
82219000
CY2014Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1225000
CY2013Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
331000
CY2014Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
1000
CY2013Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
155000
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
216000
CY2013Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
230000
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
1000
CY2013Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
2200000
CY2013Q4 us-gaap Stockholders Equity Note Subscriptions Receivable
StockholdersEquityNoteSubscriptionsReceivable
335000
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-100000
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014 atra Research And Development Expense Related Party
ResearchAndDevelopmentExpenseRelatedParty
1066000
CY2014 us-gaap Operating Expenses
OperatingExpenses
28156000
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-28156000
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-8615000
CY2014 us-gaap Interest Income Other
InterestIncomeOther
125000
CY2013 us-gaap Interest Income Other
InterestIncomeOther
12000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4093000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
17000
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-100000
CY2014 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-28106000
CY2013 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-8773000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-4110000
us-gaap Stock Issued During Period Value Issued For Cash
StockIssuedDuringPeriodValueIssuedForCash
91000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
292000
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-3727000
CY2013 atra Restricted Stock Issued To Related Party In Exchange For Notes Receivable
RestrictedStockIssuedToRelatedPartyInExchangeForNotesReceivable
331000
CY2013 us-gaap Interest Income Related Party
InterestIncomeRelatedParty
4000
CY2013 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
105000
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1713000
CY2014 us-gaap Interest Income Related Party
InterestIncomeRelatedParty
2000
CY2014 atra Note Receivable From Stockholders Collection Of Stock Subscription
NoteReceivableFromStockholdersCollectionOfStockSubscription
337000
CY2014 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
20000
CY2014 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
70000
CY2014 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
750000
CY2014 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
74573000
CY2014 us-gaap Stock Issued During Period Value Issued For Cash
StockIssuedDuringPeriodValueIssuedForCash
56456000
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
10101000
CY2014 us-gaap Other Noncash Expense
OtherNoncashExpense
750000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
2768000
CY2014 us-gaap Depreciation
Depreciation
6000
CY2013 us-gaap Depreciation
Depreciation
4000
CY2014 us-gaap Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
526000
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
10101000
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1713000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
292000
CY2014 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
2000
CY2013 us-gaap Debt Instrument Increase Accrued Interest
DebtInstrumentIncreaseAccruedInterest
4000
CY2014 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
37000
CY2013 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-27000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
39000
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
24360247
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
1524000
CY2013Q4 us-gaap Liabilities
Liabilities
1754000
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12003891
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12003891
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
12710000
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19692937
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19692937
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
48000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
48000
us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-5.60
CY2014Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2014Q4 us-gaap Assets
Assets
106122000
CY2014Q4 us-gaap Liabilities
Liabilities
2940000
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
440000
CY2013Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
432000
CY2014Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1058000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2724000
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-28006000
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-8773000
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-25000
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
170000
CY2014 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-100000
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-8603000
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
4985540
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
965825
us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
733294
CY2014 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-5.62
CY2013 us-gaap Income Loss From Continuing Operations Per Basic And Diluted Share
IncomeLossFromContinuingOperationsPerBasicAndDilutedShare
-9.08
us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
241000
CY2013 atra Research And Development Expense Related Party
ResearchAndDevelopmentExpenseRelatedParty
553000
CY2013 us-gaap Research And Development Expense Excluding Acquired In Process Cost
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
4306000
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
3018000
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3756000
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
834000
CY2013 us-gaap Operating Expenses
OperatingExpenses
8615000
us-gaap Operating Expenses
OperatingExpenses
4093000
us-gaap Operating Income Loss
OperatingIncomeLoss
-4093000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
2000
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
144169000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-40889000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
103182000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
106122000
CY2014 us-gaap Stock Issued1
StockIssued1
750000
us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
14000
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
3000
us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
17000
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.014
CY2014 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
19000
CY2013 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
210000
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
54000
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
70273000
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
53377000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
5041000
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-29718000
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
47408000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4207000
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4207000
CY2013 atra Issuance Of Convertible Preferred Stock In Exchange For License
IssuanceOfConvertiblePreferredStockInExchangeForLicense
1003000
atra Issuance Of Convertible Preferred Stock In Exchange For License
IssuanceOfConvertiblePreferredStockInExchangeForLicense
1765000
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1246000
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
158000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
35000
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-164000
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
485000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
121000
CY2014 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
-154000
CY2013 us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
148000
us-gaap Increase Decrease In Income Taxes
IncreaseDecreaseInIncomeTaxes
7000
CY2014 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
626000
CY2013 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
312000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
120000
CY2014 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
894000
CY2013 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
280000
us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
51000
CY2014 us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
78000
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-16628000
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-5966000
us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-825000
CY2014 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
95525000
CY2014 us-gaap Proceeds From Maturities Prepayments And Calls Of Shortterm Investments
ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments
12208000
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
46000
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
3000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
9000
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-83363000
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-3000
us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-9000
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
56455000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
91000
CY2014 us-gaap Proceeds From Repayments Of Notes Payable
ProceedsFromRepaymentsOfNotesPayable
337000
us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
4000
CY2014 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
13500000
CY2013 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
53587000
us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
5000000
CY2013 atra Change In Obligation To Issue Convertible Preferred Stock
ChangeInObligationToIssueConvertiblePreferredStock
-1003000
atra Change In Obligation To Issue Convertible Preferred Stock
ChangeInObligationToIssueConvertiblePreferredStock
1003000
CY2014 atra Issuance Of Common Stock Upon Vesting Of Stock Awards
IssuanceOfCommonStockUponVestingOfStockAwards
90000
CY2013 atra Issuance Of Common Stock Upon Vesting Of Stock Awards
IssuanceOfCommonStockUponVestingOfStockAwards
105000
CY2014 atra Change In Other Long Term Liabilities Related To Non Vested Stock Awards
ChangeInOtherLongTermLiabilitiesRelatedToNonVestedStockAwards
-90000
CY2013 atra Change In Other Long Term Liabilities Related To Non Vested Stock Awards
ChangeInOtherLongTermLiabilitiesRelatedToNonVestedStockAwards
226000
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
70000
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
22000
us-gaap Income Taxes Paid
IncomeTaxesPaid
9000
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates </p> <p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Significant estimates relied upon in preparing these consolidated and combined financial statements include the fair value of common stock and the fair value of preferred stock prior to our initial public offering and estimates related to clinical trial accruals and stock-based compensation expense. Actual results could differ materially from those estimates. </p></div>
CY2014 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="margin-bottom:0pt;margin-top:18pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Concentration of Credit Risk and Other Uncertainties </p> <p style="margin-bottom:0pt;margin-top:6pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">We place cash and cash equivalents in the custody of financial institutions that management believes are of high credit quality, which at times, may be in excess of the amount insured by the Federal Deposit Insurance Corporation. We also have short-term investments in money market funds, corporate bonds, US government securities, asset-backed securities and commercial paper backed by US Government or private insurers, which can be subject to certain credit risk. However, we mitigate the risks by investing in high-grade instruments, limiting our exposure to any one issuer, and monitoring the ongoing creditworthiness of the financial institutions and issuers. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:4.54%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are subject to certain risks and uncertainties and believe that changes in any of the following areas could have a material adverse effect on future financial position or results of operations: ability to obtain future financing; regulatory approval and market acceptance of, and reimbursement for, our product candidates; performance of third-party clinical research organizations and manufacturers upon which we rely; development of sales channels; protection of our intellectual property; litigation or claims against us based on intellectual property, patent, product, regulatory or other factors; and our ability to attract and retain employees necessary to support our growth. </p></div>
CY2013Q4 us-gaap Temporary Equity Shares Authorized
TemporaryEquitySharesAuthorized
102774840
CY2014 us-gaap Convertible Preferred Stock Terms Of Conversion
ConvertiblePreferredStockTermsOfConversion
The stockholders of Nina, Pinta and Santa Maria exchanged three shares of each company’s preferred stock for one share of Atara preferred stock (a collective nine-for-one basis).
CY2014Q4 us-gaap Capital Units Authorized
CapitalUnitsAuthorized
520000000
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
162461535
CY2014 atra Cancellation Of Shares Authorized Increase Decrease For Period
CancellationOfSharesAuthorizedIncreaseDecreaseForPeriod
923076
CY2014 atra Tender Of Shares Authorized Increase Decrease For Period
TenderOfSharesAuthorizedIncreaseDecreaseForPeriod
161538459
CY2014 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2012-08-01
CY2014Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.7692
CY2014 us-gaap Common Stock Conversion Basis
CommonStockConversionBasis
Nine-for-one basis
CY2014 atra Stock Authorized During Period Shares Period Increase Decrease
StockAuthorizedDuringPeriodSharesPeriodIncreaseDecrease
17948717
CY2014 dei Entity Incorporation State Country Name
EntityIncorporationStateCountryName
Delaware
CY2014 atra Cash And Cash Equivalents Maturity Period
CashAndCashEquivalentsMaturityPeriod
P90D
CY2014 atra Investment Maturity Period
InvestmentMaturityPeriod
P90D
CY2014Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
82319000
CY2014Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
3000
CY2014Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
103000
CY2014Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
82219000
CY2014Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
56752000
CY2014Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
25567000
CY2014Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
82319000
CY2014Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
56714000
CY2014Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
25505000
CY2014Q4 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
82219000
CY2014 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2014 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2014 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2014Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
12298515
CY2014Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
74600000
CY2014Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
0
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11536254
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6587828
CY2014Q4 us-gaap Property Subject To Or Available For Operating Lease Number Of Units
PropertySubjectToOrAvailableForOperatingLeaseNumberOfUnits
3
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
278000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
313000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
140000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
42000
CY2014 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
103167
CY2013 us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
57553
us-gaap Operating Leases Rent Expense Net
OperatingLeasesRentExpenseNet
8250
CY2014Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
0
CY2013Q4 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
61091000
CY2013Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
95423541
CY2013Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
95423541
CY2014 atra Stock Authorized During Period Shares New Issues
StockAuthorizedDuringPeriodSharesNewIssues
482051283
CY2014 us-gaap Stock Issued During Period Shares Share Based Compensation
StockIssuedDuringPeriodSharesShareBasedCompensation
644710
CY2014 atra Cancellation Of Outstanding Shares Increase Decrease For Period
CancellationOfOutstandingSharesIncreaseDecreaseForPeriod
923076
CY2014 atra Tender Of Shares Outstanding Increase Decrease For Period
TenderOfSharesOutstandingIncreaseDecreaseForPeriod
11725525
CY2014 us-gaap Stock Issued During Period Shares Period Increase Decrease
StockIssuedDuringPeriodSharesPeriodIncreaseDecrease
1302835
CY2014 us-gaap Stock Issued During Period Shares Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures
281826
CY2014 us-gaap Stock Issued During Period Shares Other
StockIssuedDuringPeriodSharesOther
59761
CY2014 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
5750000
CY2014Q4 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
12298515
CY2013Q4 us-gaap Common Stock Value Outstanding
CommonStockValueOutstanding
2201000
CY2014Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
3776875
CY2013Q4 us-gaap Common Stock Capital Shares Reserved For Future Issuance
CommonStockCapitalSharesReservedForFutureIssuance
122904257
CY2014 atra Expense Recognized On Employee Awards Subject To Service And Performance Conditions
ExpenseRecognizedOnEmployeeAwardsSubjectToServiceAndPerformanceConditions
5200000
CY2013 atra Expense Recognized On Employee Awards Subject To Service And Performance Conditions
ExpenseRecognizedOnEmployeeAwardsSubjectToServiceAndPerformanceConditions
1700000
atra Expense Recognized On Employee Awards Subject To Service And Performance Conditions
ExpenseRecognizedOnEmployeeAwardsSubjectToServiceAndPerformanceConditions
292180
CY2014Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
1015622
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
13768444
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Purchase Price Of Common Stock Percent
SharebasedCompensationArrangementBySharebasedPaymentAwardPurchasePriceOfCommonStockPercent
1.00
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Description And Terms
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationDescriptionAndTerms
the exercise price of an option granted to a 10% shareholder cannot be less than 110% of the estimated fair value of the shares on the date of grant. Options granted to employees and non-employees generally vest over four years and expire in seven years.
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.37
CY2012 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
292000
CY2014 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
-36000
CY2013 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
153000
CY2014 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
11000
CY2013 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
17000
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
-25000
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
170000
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.340
CY2014 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.073
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost
-0.068
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.000
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.003
us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.001
CY2014 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.001
CY2013 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.001
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.267
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.288
us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.329
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.001
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.020
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.004
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
8220000
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2874000
CY2014Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
2279000
CY2013Q4 us-gaap Deferred Tax Assets Deferred Income
DeferredTaxAssetsDeferredIncome
1121000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
1964000
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Legal Settlements
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements
757000
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Legal Settlements
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLegalSettlements
343000
CY2014Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
494000
CY2013Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
140000
CY2014Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
13714000
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
4478000
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
13714000
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
4478000
CY2014 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
9200000
CY2013 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
2900000
us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
1600000
CY2014Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
20600000
CY2013Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
7200000
CY2014 us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
Begin to expire in 2032 in various amounts if not utilized.
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1014000
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
629000
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1643000

Files In Submission

Name View Source Status
0001564590-15-001038-index-headers.html Edgar Link pending
0001564590-15-001038-index.html Edgar Link pending
0001564590-15-001038.txt Edgar Link pending
0001564590-15-001038-xbrl.zip Edgar Link pending
atra-10k_20141231.htm Edgar Link pending
atra-20141231.xml Edgar Link completed
atra-20141231.xsd Edgar Link pending
atra-20141231_cal.xml Edgar Link unprocessable
atra-20141231_def.xml Edgar Link unprocessable
atra-20141231_lab.xml Edgar Link unprocessable
atra-20141231_pre.xml Edgar Link unprocessable
atra-ex231_20141231398.htm Edgar Link pending
atra-ex311_201412317.htm Edgar Link pending
atra-ex312_201412318.htm Edgar Link pending
atra-ex321_201412319.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g20150226221933473791.jpg Edgar Link pending
g20150226221934536792.jpg Edgar Link pending
g20150226221934567793.jpg Edgar Link pending
g20150226221935083794.jpg Edgar Link pending
g20150226221935645795.jpg Edgar Link pending
g20150226221935661796.jpg Edgar Link pending
g20150226221936692797.jpg Edgar Link pending
g20150226221936708798.jpg Edgar Link pending
g20150226221939348799.jpg Edgar Link pending
g20150226221940005800.jpg Edgar Link pending
g20150226221944098801.jpg Edgar Link pending
g20150226221944677802.jpg Edgar Link pending
g20150226221946723803.jpg Edgar Link pending
g20150226221947692804.jpg Edgar Link pending
g20150226221947708805.jpg Edgar Link pending
g20150226221948224806.jpg Edgar Link pending
g20150226221949833807.jpg Edgar Link pending
g20150226221949833808.jpg Edgar Link pending
g20150226221952692809.jpg Edgar Link pending
g20150226221953333810.jpg Edgar Link pending
g20150226221954020811.jpg Edgar Link pending
g20150226222048912812.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending